Northern Trust’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3K | Hold |
51,333
| – | – | ﹤0.01% | 4368 |
|
|
2025
Q1 | $10.1K | Hold |
51,333
| – | – | ﹤0.01% | 4386 |
|
|
2024
Q4 | $27.7K | Hold |
51,333
| – | – | ﹤0.01% | 4345 |
|
|
2024
Q3 | $48.8K | Sell |
51,333
-528
| -1% | -$502 | ﹤0.01% | 4216 |
|
|
2024
Q2 | $50.6K | Sell |
51,861
-5,639
| -10% | -$5.5K | ﹤0.01% | 4213 |
|
|
2024
Q1 | $90.9K | Buy |
57,500
+77
| +0.1% | +$122 | ﹤0.01% | 4103 |
|
|
2023
Q4 | $45.5K | Hold |
57,423
| – | – | ﹤0.01% | 4251 |
|
|
2023
Q3 | $44.8K | Sell |
57,423
-1,346
| -2% | -$1.05K | ﹤0.01% | 4194 |
|
|
2023
Q2 | $54.4K | Buy |
+58,769
| New | +$54.4K | ﹤0.01% | 4203 |
|
|
2021
Q1 | – | Sell |
-50,000
| Closed | -$270K | – | 4473 |
|
|
2020
Q4 | $270K | Buy |
+50,000
| New | +$270K | ﹤0.01% | 3895 |
|